Literature DB >> 11377800

Mitochondria make a come back.

I E Scheffler1.   

Abstract

This review attempts to summarize our present state of knowledge of mitochondria in relation to a number of areas of biology, and to indicate where future research might be directed. In the evolution of eukaryotic cells mitochondria have for a long time played a prominent role. Nowadays their integration into many activities of a cell, and their dynamic behavior as subcellular organelles within a cell and during cell division are a major focus of attention. The crystal structures of the major complexes of the electron transport chain (except complex I) have been established, permitting increasingly detailed analyses of the important mechanism of proton pumping coupled to electron transport. The mitochondrial genome and its replication and expression are beginning to be understood in considerable detail, but more questions remain with regard to mutations and their repair, and the segregation of the mtDNA in oogenesis and development. Much emphasis and a large effort have recently been devoted to understand the role of mitochondria in programmed cell death (apoptosis). The understanding of their central role in mitochondrial diseases is a major achievement of the past decade. Finally, various drugs have traditionally played a part in understanding biochemical mechanisms within mitochondria; the repertoire of drugs with novel and interesting targets is expanding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377800     DOI: 10.1016/s0169-409x(01)00123-5

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  31 in total

Review 1.  Mitochondria and trypanosomatids: targets and drugs.

Authors:  Lianet Monzote Fidalgo; Lars Gille
Journal:  Pharm Res       Date:  2011-09-21       Impact factor: 4.200

Review 2.  Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

Authors:  Megan Jack; Douglas Wright
Journal:  Transl Res       Date:  2012-01-10       Impact factor: 7.012

Review 3.  Mitochondria: a target for cancer therapy.

Authors:  Jeffrey S Armstrong
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Inhibitors of metabolism rescue cell death in Huntington's disease models.

Authors:  Hemant Varma; Richard Cheng; Cindy Voisine; Anne C Hart; Brent R Stockwell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

5.  Effects of cardiolipin on membrane morphology: a Langmuir monolayer study.

Authors:  Minh Dinh Phan; Kwanwoo Shin
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

6.  Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance.

Authors:  Cheol Soo Choi; Jonathan J Fillmore; Jason K Kim; Zhen-Xiang Liu; Sheene Kim; Emily F Collier; Ameya Kulkarni; Alberto Distefano; Yu-Jin Hwang; Mario Kahn; Yan Chen; Chunli Yu; Irene K Moore; Richard M Reznick; Takamasa Higashimori; Gerald I Shulman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

7.  MitoP2, an integrated database on mitochondrial proteins in yeast and man.

Authors:  C Andreoli; H Prokisch; K Hörtnagel; J C Mueller; M Münsterkötter; C Scharfe; T Meitinger
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

8.  ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function.

Authors:  Sanghoon Kwon; Dongbum Kim; Jae Won Rhee; Jeong-A Park; Dae-Won Kim; Doo-Sik Kim; Younghee Lee; Hyung-Joo Kwon
Journal:  BMC Biol       Date:  2010-03-19       Impact factor: 7.431

9.  Re-engineering the mitochondrial genomes in mammalian cells.

Authors:  Young Geol Yoon; Michael D Koob; Young Hyun Yoo
Journal:  Anat Cell Biol       Date:  2010-06-30

Review 10.  Yeast two-hybrid, a powerful tool for systems biology.

Authors:  Anna Brückner; Cécile Polge; Nicolas Lentze; Daniel Auerbach; Uwe Schlattner
Journal:  Int J Mol Sci       Date:  2009-06-18       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.